Header Logo

Connection

DAVID NIELSEN to Opioid-Related Disorders

Back to Details
This is a "connection" page, showing publications DAVID NIELSEN has written about Opioid-Related Disorders.
DAVID NIELSEN
Connection Strength
4.911
Opioid-Related Disorders
  1. Moderation of buprenorphine therapy for cocaine dependence efficacy by variation of the Prodynorphin gene. Eur J Clin Pharmacol. 2022 Jun; 78(6):965-973.
    View in: PubMed
    Score: 0.628
  2. Pharmacogenetics of Addiction Therapy. Methods Mol Biol. 2022; 2547:437-490.
    View in: PubMed
    Score: 0.622
  3. The OPRD1 rs678849 variant influences outcome of disulfiram treatment for cocaine dependency in methadone-maintained patients. Psychiatr Genet. 2021 06 01; 31(3):88-94.
    View in: PubMed
    Score: 0.597
  4. Neurobiology of Opioid Use Disorder and Comorbid Traumatic Brain Injury. JAMA Psychiatry. 2018 06 01; 75(6):642-648.
    View in: PubMed
    Score: 0.485
  5. Opioid Use Disorder After Self-medicating Pain From Traumatic Brain Injury. JAMA Psychiatry. 2018 06 01; 75(6):649-650.
    View in: PubMed
    Score: 0.485
  6. Epigenetic variation in OPRM1 gene in opioid-exposed mother-infant dyads. Genes Brain Behav. 2018 09; 17(7):e12476.
    View in: PubMed
    Score: 0.481
  7. The role of opioidergic genes in the treatment outcome of drug addiction pharmacotherapy: A systematic review. Am J Addict. 2015 Jan; 24(1):15-23.
    View in: PubMed
    Score: 0.383
  8. Pharmacogenetic randomized trial for cocaine abuse: disulfiram and dopamine ?-hydroxylase. Biol Psychiatry. 2013 Feb 01; 73(3):219-24.
    View in: PubMed
    Score: 0.325
  9. Common and specific liability to addiction: approaches to association studies of opioid addiction. Drug Alcohol Depend. 2012 Jun; 123 Suppl 1:S33-41.
    View in: PubMed
    Score: 0.318
  10. Pharmacogenetics and human molecular genetics of opiate and cocaine addictions and their treatments. Pharmacol Rev. 2005 Mar; 57(1):1-26.
    View in: PubMed
    Score: 0.194
  11. Increased habenular connectivity in opioid users is associated with an a5 subunit nicotinic receptor genetic variant. Am J Addict. 2017 Oct; 26(7):751-759.
    View in: PubMed
    Score: 0.115
  12. Evidence for association of two variants of the nociceptin/orphanin FQ receptor gene OPRL1 with vulnerability to develop opiate addiction in Caucasians. Psychiatr Genet. 2010 Apr; 20(2):65-72.
    View in: PubMed
    Score: 0.069
  13. Search for genetic markers and functional variants involved in the development of opiate and cocaine addiction and treatment. Ann N Y Acad Sci. 2010 Feb; 1187:184-207.
    View in: PubMed
    Score: 0.068
  14. Catechol-O-methyltransferase (COMT) gene variants: possible association of the Val158Met variant with opiate addiction in Hispanic women. Am J Med Genet B Neuropsychiatr Genet. 2008 Sep 05; 147B(6):793-8.
    View in: PubMed
    Score: 0.062
  15. Redefinition of the human kappa opioid receptor gene (OPRK1) structure and association of haplotypes with opiate addiction. Pharmacogenetics. 2004 Dec; 14(12):793-804.
    View in: PubMed
    Score: 0.048
  16. Pharmacogenetic randomized trial for cocaine abuse: disulfiram and a1A-adrenoceptor gene variation. Eur Neuropsychopharmacol. 2013 Nov; 23(11):1401-7.
    View in: PubMed
    Score: 0.022
  17. Genes associated with addiction: alcoholism, opiate, and cocaine addiction. Neuromolecular Med. 2004; 5(1):85-108.
    View in: PubMed
    Score: 0.011
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.